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Abstract
Background: The wide use of healthy persons as kidney donors calls for awareness of risks associated with
donation. Live kidney donation may impair quality of life (QOL) and result in fatigue. Long-term data on these
issues are generally lacking in the donor population. Thus we aimed to investigate long-term self-reported health
outcomes in a nationwide donor cohort.
Methods: We assessed self-reported QOL, fatigue and psychosocial issues after donation in 217 donors
representing 63 % of those who donated 8–12 years ago. QOL was measured using the generic Short Form-36
Health Survey (SF-36), fatigue using the Multidimensional Fatigue Inventory (MFI) and psychosocial issues using
donor specific questions. For each of the 8 domains of SF-36 and the 5 domains of MFI, we performed generalized
linear regression.
Results: Donors scored high on QOL with mean scores between 63.9 and 91.4 (scale 1–100) for the 8 subscales.
Recognition from family and friends was associated with higher QOL scores in four domains. There were no
significant gender differences. Fatigue scores were generally low. Females generally scored higher than males on all
five dimensions of fatigue, although significantly only on two. Recipient still alive was associated with lower scores
on mental fatigue. Regretting donors scored higher than average on all domains of fatigue. Recipient death, worries
about own health and worsened relationship with the recipient influenced willingness to donate in retrospect.
Donor age did not affect long-term health outcomes.
Conclusions: Eight till 12 years after donation QOL scores were generally high and improved with recogniton from
family and friends. Fatigue was independent of donor age and more pronounced in females and in those who
regretted donation.
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Background
End stage renal disease is an escalating health problem
worldwide, with kidney transplantation being the gold
standard treatment. Due to the increasing shortage of
organs from deceased donors, transplantation with live
kidney donor (LKD) has increased by 50 % [1], and in
some countries, more than half of kidney transplants are
live donor kidneys. The introduction of laparoscopic
donor nephrectomy with a less traumatic surgery has
boosted the use of LKD and also allowed for more exten-
sive use of elderly donors. The wide use of healthy persons
as kidney donors for the benefit of others calls for aware-
ness to the risks associated with donation. Beyond the sur-
gical and medical risks, there is evidence suggesting that
live donation is associated with a decreased donor quality
of life (QOL) and increased fatigue [2–4].
It seems to be a gender difference in who become live
donors, and in several studies female donors outnumber
male donors [3, 5–7]. Tumin and colleagues performed
a comparison of QOL between donors and a control
group [6]. They found a gender and age difference in
scores among the donors and that male donors and
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donors older than 56 years had higher scores. A study
comparing younger and elderly kidney donors showed
that LKDs who were older than 60 years at the time of
donation recovered faster in terms of QOL than younger
donors who did not recover completely in all the do-
mains within one year [8]. Importantly, long-term data
on the associations between high donor age or gender
differences are lacking.
Various factors other than age have also shown associ-
ations with QOL and fatigue post-donation, such as rela-
tionship to the recipient, pre-donation expectations,
donation-related experience, transplant outcome and
support from health professionals, family and friends
[2, 3, 9, 10]. Furthermore, positive experiences and
perceptions of support seem to be protective, while
reduced QOL has been related to fatigue, pain, long
recovery time and recipient graft-failure.
Altogether, the knowledge about long-term conse-
quences of donor nephrectomy is sparse because most
existing follow-up studies have a shorter time-span than
10 years [9, 11, 12], a variable time-span [3, 5, 13], and
some have small samples [2, 6, 11, 14]. New data about
long-term consequences after donation may provide a
better basis for safe expansion of donor selection criteria
[4, 15], informed consent [16, 17] and guidelines for
long-term follow-up [18].
The present study is unique in the sense that this in-
vestigation uses a nationwide cohort that has been
followed for 8–12 years. The aims were to investigate
factors associated with long-term self-reported QOL and
fatigue with particular reference to age groups.
Methods
The study was approved by the Regional Medical Re-
search Committee for Health South East of Norway
(2011/2595 D) and the hospital’s data protection officer.
The results are presented in such a way that no individ-
ual can be recognized in any publication or presentation
of the data. This study was designed to investigate QOL
and fatigue in LKDs representing all parts of Norway.
Study design and population
A cross-sectional survey was performed using eligible
Norwegian kidney donors (N = 351) who donated a kidney
at Oslo University Hospital, the Norwegian transplant
center, between 2001–2004. The eligible donors were in-
vited by mail, including one reminder, to participate in the
study. The invitation letter included information about
the purpose of the study and ensured confidentiality. To
be as close as possible to 10 years follow-up for all LKD,
those who donated in 2001 and 2002 received the invita-
tion in November 2012 and LKD who donated in 2003
and 2004 were invited in May 2013. Figure 1 shows a dia-
gram of the inclusion criteria; 262 donors who agreed to
participate were sent the questionnaire booklet, and in-
formed consent to partake in the study was given by the
217 donors who returned the questionnaire.
Questionnaires
QOL
To measure QOL, we used the generic Short Form-36
Health Survey (SF-36v2®) [19]. The instrument includes 36
items and evaluates a physical (PCS) and mental (MCS)
LKD at Oslo university hospital  
01.01.2001-31.12.2004 
(n=365)
Excluded due to death 
or living abroad (n=14)  
Eligible for inclusion (n=351) 
Unsuccessful contact 
attempts (n=5) 
Invited to participate (n=346) 
Reminder sent (n=123) 
Responded to 
reminder (n=48) 
Consent to participation (n=262)  
Received qustionnaire booklet 
Did not return qustionnaire booklet 
Returned questionnaire 
booklet (n=217) 
Fig. 1 Inclusion criteria flow diagram. The diagram describes how the sample of living kidney donors (LKD) who completed the questionnaires
for this study (N = 217) was derived from the total donors at Oslo university hospital in 2001–2004
Meyer et al. BMC Nephrology  (2016) 17:8 Page 2 of 10
component score in addition to eight different domains:
physical functioning (PF), role physical (RP), vitality (VT),
mental health (MH), role emotional (RE), social function-
ing (SF), general health (GH), and bodily pain (BP). Each of
the eight subscales has a theoretical range of 0–100, and
lower scores indicate reduced QOL. The instrument has
been translated into and validated in Norwegian [20] and
has been used in several studies among LKD [2, 3, 14, 21].
Fatigue
The Multidimensional Fatigue Inventory (MFI) (22) was
used to measure fatigue, which includes 20 items cover-
ing the following five dimensions: general fatigue (GF),
physical fatigue (PF), mental fatigue (MF), reduced motiv-
ation (RM) and reduced activity (RA). Each subscale has a
theoretical range of 4–20, and a higher score indicates
more fatigue. MFI has been translated into Norwegian
and validated [22] and is used in other studies to measure
fatigue after kidney donation [2, 11, 14, 23].
Donor specific questions
The participants also responded to donor specific ques-
tions, measuring psychosocial and clinical factors, such
as regret of donation (yes/no/do not know), recipient
outcome (from much better than expected to much
worse than expected), economic problems (from to a
great extent to not at all), regular follow-up (from annu-
ally to never), recognition from family, friends and
health professionals (from to a great extent to not at all),
use of analgesics or tranquilizers/ hypnotics (from daily
to never) and satisfaction with life before and after dona-
tion (from very satisfied to very dissatisfied) [21].
Demographic variables
Demographic variables included age, gender, marital sta-
tus, educational level, vocational status and relationship
to the recipient.
Statistical analyses
The descriptive data are presented with frequencies and
percentages. Due to the skewed distribution of QOL and
fatigue, we used the non-parametric independent samples
Wilcoxon Mann-Whitney U-test to test for differences in
QOL and fatigue between males and females, and elderly
and younger donors (<60 years or ≥ 60 years at donation
time). To examine factors that may be associated with
QOL and fatigue 10 years post-donation we used general-
ized linear model with gamma family and log link, as de-
fault. For regressions where gamma family and log link was
not appropriate, we used Poisson with log link or gamma
with identity link. Independent variables were recipient
outcome, feeling responsibility for recipient’s health, recog-
nition from family and friends, and health professionals’,
use of analgesics and tranquilizers/hypnotics, and donor’s
relationship to the recipient. Covariates were recognized
demographics, such as age groups, gender, marital status
and vocational status. The generalized linear model with
Poisson family was used to investigate any association be-
tween the abovementioned factors and overall satisfaction
with life 10 years after donation. One way ANOVA was
used to examine the relationship between feeling respon-
sible for the recipient’s health and expectations for the re-
cipient’s health. Missing data were treated according to the
manual for SF-36v2 ® [24] and for fatigue and donor spe-
cific questions treated as missing. A two-tailed p-value less
than 0.05 was regarded as statistically significant. All ana-
lyses were performed using the statistical package for social
sciences version 21 (SPSS Inc. Chicago, IL, USA). Testing
for appropriate link function and family for generalized
linear regression was done with linktest in STATA 13.1
(StataCorp, College Station, Texas, USA).
Results
Demographics and relationship to the recipient
The response rate was 63 % and median follow-up time
was 10 years (range 8.5–12 years). Table 1 shows the
characteristics of the donors by age group, older and
younger than 70 years at the time of follow-up (60 years
at donation). Overall, the mean age of the donors at
follow-up was 59.5 years (range 31–91) and 34 (15.7 %)
of the donors were 70 years or older. The majority
(63.6 %) were females, and the most common relation-
ship to the recipient was sibling (33.2 %) followed by
parent (24.4 %). Parents were more represented in the
elderly group, and more elderly donors were widowed
and retired compared to younger donors. No new infor-
mation was found about associations between self-
reported QOL and fatigue, and the covariates marital
status, educational level and vocational status
QOL
QOL scores evaluated by the SF-36 questionnaire are
shown in Table 2. Females scored significantly lower in
the domains RP and RE. There were no differences be-
tween donors <70 years or donors ≥70 years of age at
follow up.
Fatigue
Results of measures of the different dimensions of fa-
tigue tested with the MFI questionnaire are shown in
Table 3. Females scored significantly higher than
males on most scales. No differences in scores between
donors < 70 years and ≥ 70 years of age were found.
Donor specific questions
Nearly all LKDs (94 %) would have donated again; only
seven (3.2 %) would not. Among those seven, there were
donors who perceived that the donation had been
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harmful to own health, the relationship with the recipi-
ent had worsened, or reported the recipient had lost the
graft or died. Thirteen LKDs (6 %) believed the donation
had been harmful to his or her own health. Sixteen
LKDs (7.4 %) reported economic problems related to the
donation, nine (4 %) claimed loss of income was the rea-
son, and the donation had caused a change in vocation
for 11 donors (5 %). Twenty three LKDs (10.7 %) used
tranquilizers/hypnotics and 31 (14.4 %) used analgesics
daily or every week. Female donors were more frequent
users than male donors; 13.9 % vs. 5.2 % and 19.7 % vs.
5.1 % respectively. More than half of the LKDs (54.4 %)
did not see a nephrologist for medical follow-up in the
long-term after donation, while 55 (25.3 %) had regular
visits every year or every other year. As illustrated in
Fig. 2, LKDs perceived more recognition from family
and friends than from healthcare personnel (p < 0.001).
The majority (71.5 %) reported to perceive that the re-
cipient’s health was better than or as they had expected.
Responsibility for the recipients health was pereceived
by nearly half of the donors, 35 % felt some responsibil-
ity and 12 % felt a great extent of responsibility for the
Table 2 QOL scores by age and gender
SF-36 Subscales Total sample Age groups Gender
Mean (SD) n <70y ≥70y P Male Female P
Physical function 208 89.7 (15.7) 90.1 (15.2) 86.1 (19.2) 0.29 92.4 (12.1) 87.8 (17.6) 0.13
Role physical 214 86.3 (24.2) 85.8 (24.8) 86.6 (25.1) 0.36 91.8 (20.7) 82.4 (26.4) 0.01*
Bodily pain 216 76.8 (26.0) 76.8 (26.2) 79.1 (25.7) 0.76 81.5 (22.9) 74.5 (27.5) 0.11
General health 213 80.5 (21.0) 81.6 (20.4) 78.5 (22.2) 0.16 85.6 (15.8) 78.6 (22.7) 0.12
Vitality 214 63.9 (22.9) 64.3 (23.4) 62.0 (23.3) 0.38 68.2 (22.2) 61.5 (23.7) 0.11
Social function 214 88.9 (20.2) 89.4 (19.7) 86.1 (23.1) 0.23 91.9 (16.5) 87.2 (21.9) 0.17
Role emotional 216 91.4 (17.0) 91.6 (17.2) 89.2 (19.3) 0.13 95.3 (10.9) 88.9 (20.1) 0.03*
Mental health 216 82.6 (16.1) 82.7 (16.2) 82.0 (15.9) 0.43 84.9 (15.1) 81.3 (16.7) 0.20
Non-parametric independent samples, Wilcoxon, Mann-Whitney U- test: Values are given as mean (SD), P-value is asymp. 2-tailed, *p < 0.05
Table 1 Donor demographics and relationship to recipient by age groups
All donors <70 years >70 years
n n n p
Donors 217 (100 %) 183 (84.3 %) 34 (15.7 %)
Gender 0.59
Female 138 (63.6 %) 115 (62.8 %) 23 (67.6 %)
Male 79 (36.4 %) 68 (37.2 %) 11 (32.4 %)
Marital status 0.04*
Single/divorced/widowed 52 (24 %) 39 (21.3 %) 13 (38.2 %)
Married/cohabitant 164 (75.6 %) 143 (78.1 %) 21 (61.8 %)
Educational level 0.88
High school or less 120 (55.3 %) 101 (55.2 %) 19 (55.9 %)
College or university 93 (42.9 %) 79 (43.2 %) 14 (41.2 %)
Vocational status 0.00*
Employed 147 (67.7 %) 139 (76 %) 7 (20.6 %)
Not employed 70 (32.3 %) 42 (23 %) 27 (79.4 %)
Donor’s relation to recipient 0.04*
Offspring 23 (10.6 %) 22 (12.0 %) 1 (2.9 %)
Parents 53 (24.4 %) 39 (21.3 %) 14 (41.2 %)
Sibling 73 (33.6 %) 64 (35.0 %) 8 (23.5 %)
Spouse 37 (17.1 %) 29 (15.8 %) 8 (23.5 %)
Other 31 (14.3 %) 27 (14.8 %) 3 (8.8 %)
Pearson’s chi square: P-value is between age groups, asymp 2-tailed, *p < 0.05
Educational level comprise 213 donors, 4 unknown
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recipient’s health. There was a relationship between the
donor’s feeling of responsibility and the perceived health
of the recipient at follow-up (p = 0.002). The feeling of
responsibility was highest when perceived health of the
recipient was much better than expected.
As shown in Table 4, the donors’ perception of recog-
nition from family and friends was associated with the
SF-36 dimensions RP, BP, VT and RE. There was no
association between recipient outcome or the donor
feeling responsible for recipient’s health and QOL.
Table 5 shows the associations between the dimen-
sions of fatigue and donor specific questions and demo-
graphics. There were no associations between donor’s
self-reported fatigue and responsibility for recipient
health, recognition from others, or relationship to recipi-
ent at follow-up. As illustrated in Fig. 3 recipient’s death
was significantly associated with higher scores in the
MFI dimensions GF, PF, RA and RM.
Overall satisfaction with life 10 years after donation was
positively associated with perceived recognition from
health personnel (p < 0.01) and negatively associated with
donors being younger than 70 years (p < 0.001).
LKDs who would not have donated again had higher
mean scores than the average on all domains of MFI; GF
(12.9), PF (13.4), RA (11.4) RM (11.0) and MF (10.4).
Discussion
This study shows that the donors generally perceive
their QOL as good, and also report a low degree of fa-
tigue at 10 years after donation. The results are in line
with studies reporting a good QOL in the short-term
after transplantation [9, 11, 12]. However, in a follow-up
study 10 years after donation Klop et al. reports both ex-
cellent health and a deviation from baseline values in
several domains of QOL and fatigue [14]. The authors
argue that the difference may be explained by an increase
in age of 10 years. In the present survey representing
a nationwide selection of donors followed according
to European recommendations [18, 25] the research de-
sign did not allow for baseline data or a control group.
However, approximately one third of the participants in
this survey also participated in a Norwegian randomized
study comparing laparoscopic and open donor nephrec-
tomy [21]. The good health reported in the present study
appears to be sustained long-term. Thus our study pro-
vides new knowledge about the long-term self-reported
health outcomes that may have implications concerning
information provided to future donors.
In the present study, a significant finding was the dif-
ference between males and females in the MFI for all
domains except RA, and in the domains RP and RE in
Table 3 Fatigue scores by age group and gender
MFI Scale scores Total sample Age groups Gender
Mean (SD) n <70y ≥70y p Male Female P
General fatigue 207 8.8 (4.4) 8.8 (4.5) 8.4 (4.0) 0.89 7.7 (3.8) 9.3 (4.6) 0.01*
Physical fatigue 209 8.2 (4.2) 8.1 (4.1) 8.7 (4.5) 0.28 7.3 (3.6) 8.7 (4.4) 0.01*
Reduced activity 211 8.3 (4.1) 8.2 (3.9) 8.6 (4.3) 0.26 7.7 (3.5) 8.5 (4.2) 0.09
Reduced motivation 208 7.3 (3.1) 7.1 (3.0) 7.0 (2.6) 0.61 6.7 (2.9) 7.4 (3.0) 0.04*
Mental fatigue 212 8.0 (3.5) 8.0 (3.6) 8.1 (2.9) 0.25 7.4 (3.5) 8.3 (3.5) 0.03*



























Recognition family and friends Recognition health personnel
P<0.001 
Fig. 2 Responses to donor specific questions according to levels of agreement (per cent)
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Table 4 Associations between QOL scores (SF-36) and donor specific questions
Physical functiona Role physicalb Bodily painb General healtha Vitalityb Social functiona Role emotionala Mental healtha
n 159 164 166 163 163 167 166 166
Recognition
Family and friends B (st.error) 3.242 (2.004) 7.984* (4.029) 7.490* (3.153) 0.063 (0.041) 6.776* (3.077) 0.048 (0.039) 0.055* (0.028) 0.045 (0.030)
Health personnel B (st.error) 0.342 (1.322) 1.527 (2.830) 2.890 (2.496) 0.001 (0.027) 0.949 (2.266) 0.010 (0.025) 0.009 (0.017) 0.014 (0.020)
Recipient’s outcome
Still alive B (st.error) 1.458 (4.705) 0.499 (9.913) 5.959 (8.205) −0.027 (0.097) 0.363 (7.799) 0.036 (0.092) 0.034 (0.064) 0.075 (0.071)
Responsibility
Feeling responsible for recipient’s health B (st.error) −0.612 (1.093) 3.277 (2.420) 1.271 (2.100) 0.008 (0.023) 0.754 (1.862) 0.020 (0.021) 0.021 (0.015) 0.003 (0.016)
Donor’s relationc
Offspring B (st.error) −0.126 (4.556) 2.923 (9.282) 1.725 (8.156) 0.054 (0.094) −4.816 (7.850) −0.149 (0.089) −0.066 (0.062) −0.041 (0.070)
Parents B (st.error) 0.021 (3.974) 8.459 (8.275) 8.052 (7.699) 0.068 (0.082) −5.203 (7.059) −0.104 (0.077) −0.023 (0.054) −0.001 (0.061)
Sibling B (st.error) −0.777 (3.553) 3.039 (7.351) 3.450 (6.724) 0.040 (0.074) −0.410 (6.417) −0.097 (0.069) −0.001 (0.048) 0.016 (0.054)
Spouse B (st.error) −1.627 (4.201) 4.645 (8.266) 3.094 (7.602) 0.031 (0.084) −5.367 (7.041) −0.121 (0.080) −0.052 (0.056) −0.031 (0.062)
Use of analgesicd
Daily/every week B (st.error) −8.034* (4.001) −15.978 (8.639) −20.299** (7.117) −0.057 (0.081) −4.438 (6.827) −0.042 (0.077) −0.096 (0.054) 0.005 (0.061)
Use of relaxant/ sleeping pillse
Daily/every week B (st.error) −17.378** (4.817) −11.263 (8.498) −0.169 (8.631) −0.116 (0.093) −17.494** (6.437) −0.095 (0.086) −0.133* (0.060) −0.099 (0.070)
Genderf
Male B (st.error) 4.355 (2.532) 6.980 (5.889) 3.118 (5.011) 0.079 (0.053) 4.853 (4.832) 0.044 (0.050) 0.045 (0.035) 0.035 (0.039)
Agegroupg
<70 years B (st.error) 4.419 (4.060) 3.637 (8.356) 7.450 (7.430) 0.070 (0.082) 5.565 (6.824) 0.079 (0.077) 0.076 (0.054) 0.020 (0.060)
Medical follow-uph
No regular controls B (st.error) −2.743 (2.360) −2.947 (4.985) −0.842 (4.419) −0.062 (0.049) 0.016 (4.417) 0.018 (0.046) −0.028 (0.032) −0.011 (0.036)
Generalized linear model: Each domain was analyzed separately; aGamma with log link, bGamma with identity; B, the regression coefficient; reference was: crelation category friends/others, dless than every week/never,













the SF-36. The gender difference in self-reported fatigue
in our study differs from the results in a study on fatigue
and physical function in mid-life [26]. Boter and col-
leagues found a strong association between physical func-
tion and the subscales in MFI but no gender difference.
However, gender difference in fatigue is inconsistent in
previous studies. While a study on the German population
demonstrated a significant difference [27], the gender
difference was present but not significant in a Swedish
study [28], and a Danish study showed that while there
Table 5 Associations between fatigue scores (MFI) and donor specific questions
General fatiguea Physical fatigueb Reduced activitya Reduced motivationa Mental fatiguea
n 163 163 163 161 164
Recognition
Family and friends B (st.error) −0.021 (0.080) 0.066 (0.425) −0.003 (0.058) 0.038 (0.049) −0.016 (0.054)
Health personnel B (st.error) −0.038 (0.038) −0.130 0.264 0.010 (0.039) −0.012 (0.030) −0.038 (0.034)
Recipient’s outcome
Still alive B (st.error) 0.113 (0.141) −0.172 (1.060) 0.011 (0.133) 0.086 (0.110) 0.363** (0.126)
Responsibility
Feeling responsible for recipient’s health B (st.error) 0.051 (0.033) 0.095 (0.238) 0.002 (0.032) −0.008 (0.026) −0.015 (0.030)
Donor’s relationc
Offspring B (st.error) −0.025 (0.135) 0.952 (0.895) 0.218 (0.130) 0.023 (0.107) 0.110 (0.122)
Parents B (st.error) −0.005 (0.118) 0.660 (0.763) 0.103 (0.114) −0.001 (0.092) −0.047 (0.106)
Sibling B (st.error) 0.064 (0.104) 0.832 (0.653) 0.140 (0.099) 0.094 (0.082) 0.040 (0.094)
Spouse B (st.error) 0.135 (0.126) 0.366 (0.809) 0.208 (0.119) 0.067 (0.099) 0.091 (0.111)
Use of analgesicd
Daily/ every week B (st.error) 0.356** (0.115) 3.599** (1.168) 0.258* (0.110) 0.071 (0.094) 0.158 (0.104)
Use of relaxant/ sleeping pillse
Daily/ every week B (st.error) 0.261* (0.128) 2.552* (1.277) 0.321* (0.125) 0.363*** (0.103) 0.161 (0.116)
Genderf
Male B (st.error) −0.196* (0.078) −1.139* (0.489) −0.037 (0.072) −0.072 (0.060) −0.068 (0.068)
Agegroupg
<70 years B (st.error) −0.088 (0.117) −1.298 (0.889) 0.017 (0.114) 0.016 (0.092) −0.093 (0.103)
Medical follow-uph
No regular controls B (st.error) −0.009 (0.071) 0.299 (0.476) −0.006 (0.068) −0.009 (0.055) −0.078 (0.063)
Generalized linear modell: each domain was analyzed separately; aGamma with log link, bGamma with identity; B, the regression coefficient; reference was:
crelation category friends/others, dless than every week/never, eless than every week/never, ffemale, gage ≥ 70 years, hno controls; controlled for covariates marital








GF PF RA RM MF
Recipient still alive Recipient dead
P<0.05 P<0.01 P<0.05 P<0,05
Fig. 3 Donors’ mean scores on dimensions of fatigue when recipient was still alive or dead ten years after donation
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was no general gender difference there seemed to be an
excess of females with high scores [29]. Only few studies
[2, 11, 14, 23] have specifically investigated fatigue after
live donation, and as far as we know, none have examined
the gender difference. Our results indicate that females
may experience fatigue after donation. Since the majority
of the donors are female it seems important to include in-
formation about fatigue in pre-donation information.
Another particular aspect of the present study was the
effect of donation on the elderly population because eld-
erly donors are frequently used. We defined an elderly
donor as older than 60 years of age at the time of dona-
tion (70 years at follow-up) for comparison with previ-
ous studies on elderly donors [7, 30]. Even though there
has been reported a linear relationship between dimen-
sions of fatigue in MFI and age in a general population
[27], we found no difference in self-reported fatigue
between younger and older donors in the long-term.
Nor did we find a difference in self-reported QOL.
These results are in line with results from short-term
observations [7, 30] and confirm the results from the
long-term RELIVE study [3]. The elderly donors in
our study also scored higher than the elderly participants
(more than 70 years) in the Norwegian general population
[20]. Although we have to have in mind that the nor-
mative data are nearly 20 years old, the long-term
self-reported health seems not to be impaired in elderly
donors. These results are reassuring for both clinicians
and elderly persons considering being a kidney donor.
The large majority of the donors did not regret dona-
tion and would be willing to donate again as has been
reported in many follow-up studies [11, 12, 31]. How-
ever, a small minority would say no if they were asked
again, and the higher scores in fatigue in these donors
call for attention. Fatigue among donors who regret do-
nation has not been studied before and needs further in-
vestigation. We found that some of those who regretted
donation had experienced recipient death. Our data also
showed an association between fatigue and recipient
death. This is in line with previous research which has
demonstrated that recipient death can produce a feeling
of guilt [32] and influence LKD’s well-being [10, 33]. In
addition, there were donors who had experienced a
negative change in the relationship with the recipient,
which may be disappointing. Furthermore, three of those
who regretted donation perceived that the donation had
been harmful to his or her health. Worrying about own
health may have provoked or contributed to the percep-
tion of fatigue. The real challenge would be to identify
donors at risk for regret during donor work-up. Unfortu-
nately, this aspect could not be addressed in the present
study but paying attention to those who donate to a re-
cipient at high-risk may be appropriate. Adverse out-
comes for the recipient have also been found to be
associated with adverse psychosocial outcomes for LKD
in previous studies [10, 32, 33]. However, for the donor
population as a whole, the donors in our study did not
blame themselves if the result was poor. Nevertheless,
recipient outcome better than expected and recipient
still alive was associated with a positive emotional out-
come and seemed to generate more responsibility among
the donors.
Both live and deceased donation is generally acknowl-
edged to be a good deed. Appreciation and recognition
of the deed they have accomplished from the social en-
vironment in addition to improved recipient health may
provide improved self-esteem and personal growth,
which again may be associated with QOL and satisfac-
tion with life. Findings from previous studies [32, 34, 35]
such as changed roles, improved self-esteem, personal
growth, and improved QOL among donors support this
conclusion.
While Tong et al. [32] found that donors worry about
potential kidney failure, physical well-being and ill
health, a minority in our study considered the donation
to be harmful to his or her health. The low number of do-
nors who had regular visits to a nephrologist may both re-
flect that LKDs are healthy persons going through an
extensive work-up ahead of the donation and that most
recover within the first year post-donation. However, to
obtain knowledge about the long-term consequences and
ensure quality and safety, regular follow-up is essential
[18, 36]. In Norway, which is a fairly small country and
has limited mobility within the population, the possibility
for medical follow-up for most donors may be better than
in vast countries such as the USA [3, 36]. Still, less than
half of the donors in the present study had medical
follow-up 10 years after donation.
The strength of the present study is the sample size with
a fairly high response rate 8–12 years after donation and
representation from all parts of Norway [37]. The demo-
graphics and characteristics of the non-responders are
similar to that of the responders. The data sets also had
few missing data. We have used well-established methods
previously validated in Norwegian populations. A limita-
tion of cross-sectional follow-up studies is the lack of
baseline data and a control group. Consequently, we do
not know if there has been a change in self-reported out-
comes 8–12 years after donation. Additionally, we do not
have any information about the motivations to donate.
There might be a recall bias in self-report up to 12 years
later. Another limitation in this study is that we did not
link our data to a recipient registry. However, we tried to
restrict the weakness by questions about donors’ expecta-
tions and recipient outcome. We have contributed to new
knowledge as seen from the donors’ perspective which re-
cently was highlighted in the report from Thiessen et al
(2015) as essential in the care of LKD.
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Conclusions
The long-term QOL of donors was reported as good
both in younger and older donors and improved with
recognition from family and friends. Female donors had
higher scores on fatigue than male donors. A few donors
regretted donation and those donors reported a high
level of fatigue. Identifying and following donors who
are at risk for regretting donation is important. More re-
search is needed on gender differences and factors that
are associated with fatigue after live kidney donation in
the long-term compared to baseline data.
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